References
- Woo PC, Huang Y, Lau SK, Yuen KY "Coronavirus genomics and bioinformatics analysis". Viruses. August 2010. 2 (8): 1804–20. doi:10.3390/v2081803. PMC 3185738. PMID 21994708. Coronaviruses possess the largest genomes (26.4 kb (ThCoV HKU12) to 31.7 kb (SW1)) among all known RNA viruses (Figure 1) (2,13,16).
- Novel Ehrlichia Strain Infecting Cattle Tick Amblyomma neumanni, Argentina, 2018 Lucía Fargnoli, Camilo Fernandez, Lucas D. Monje Author affiliation: Instituto de Ciencias Veterinarias del Litoral, UNL-CONICET, Esperanza, Argentina DOI: https://doi.org/10.3201/eid2605.190940
- Coronaviruses. Niaid.nih.gov 2021. Retrieved 23 May 2021, from https://www.niaid.nih.gov/diseases-conditions/coronaviruses
- Parry, N. COVID-19 and pets: When pandemic meets panic. Forensic Science International 2020: Reports, 2, 100090. https://doi.org/10.1016/j.fsir.2020.100090
- Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. "The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2". Nature Microbiology. March 2020. 5 (4): 536–544. Doi:10.1038/s41564-020-0695-z. PMC 7095448. PMID 32123347.
- "Coronavirus disease named Covid-19". BBC News Online. 11 February 2020. Archived from the original on 15 February 2020. Retrieved 15 February 2020.
- Ozsahin, I., Sekeroglu, B., Musa, M., Mustapha, M., & Uzun Ozsahin, D. Review on Diagnosis of COVID-19 from Chest CT Images Using Artificial Intelligence. Computational and Mathematical Methods in Medicine, 2020, 1-10. https://doi.org/10.1155/2020/9756518
- "COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)". ArcGIS. Johns Hopkins University. Retrieved 2021-04-24.
- "COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)". ArcGIS. Johns Hopkins University. Retrieved 2021-04-24.
- Santacroce, L., Charitos, I., Carretta, D., De Nitto, E., & Lovero, R. The human coronaviruses (HCoVs) and the molecular mechanisms of SARS-CoV-2 infection. Journal of Molecular Medicine, 2020. 99(1), 93-106. https://doi.org/10.1007/s00109-020-02012-8
- Cohen J (2020-01-26). "Wuhan seafood market may not be the source of the novel virus spreading globally". ScienceMag American Association for the Advancement of Science. (AAAS). Archived from the original on 2020-01-27. Retrieved 2020-01-29.
- Eschner K (2020-01-28). "We're still not sure where the COVID-19 really came from". Popular Science. Archived from the original on 2020-01-30. Retrieved 2020-01-30.
- Clinical characteristics of COVID-19. European Centre for Disease Prevention and Control. (2021). Retrieved 1 May 2021, from https://www.ecdc.europa.eu/en/covid-19/latest-evidence/clinical
- Benefits of Getting a COVID-19 Vaccine. Centers for Disease Control and Prevention. (2021). Retrieved 23 May 2021, from https://www.cdc.gov/coronavirus/2019-ncov/vaccines/vaccine-benefits.html
- Luo, R., Delaunay‐Moisan, A., Timmis, K., & Danchin, A. SARS‐CoV ‐2 biology and variants: anticipation of viral evolution and what needs to be done. Environmental Microbiology, 2021. 23(5), 2339-2363. https://doi.org/10.1111/1462-2920.15487
- Doulberis, M., Papaefthymiou, A., Kotronis, G., Gialamprinou, D., Soteriades, E., & Kyriakopoulos, A. et al. Does COVID-19 Vaccination Warrant the Classical Principle “ofelein i mi vlaptin”?. Medicina, 2021.57(3), 253. https://doi.org/10.3390/medicina57030253
- Brans, J., & Vincke, P. Note- A Preference Ranking Organization Method. Management Science, 1985, 31(6), 647-656. https://doi.org/10.1287/mnsc.31.6.647
- Macharis, C., Springael, J., De Brucker, K., & Verbeke, A. PROMETHEE and AHP: The design of operational synergies in multi-criteria analysis. European Journal of Operational Research, 2004. 153(2), 307-317. https://doi.org/10.1016/s0377-2217 (03)00153-x.
- Wouters, O., Shadlen, K., Salcher-Konrad, M., Pollard, A., Larson, H., Teerawattananon, Y., & Jit, M. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. The Lancet, 2021. 397(10278), 1023-1034. https://doi.org/10.1016/s0140-6736 (21)00306-8.
- Abdullah, L., Chan, W., & Afshari, A.. Application of PRO-METHEE method for green supplier selection: a comparative result based on preference functions. Journal of Industrial Engineering International, 2018. 15(2), 271-285. https://doi.org/10.1007/s40092-018-0289-z
- Nakajima, Y., Fujii, T., Mukai, K., Ishida, A., Kato, M., & Takahashi, M. et al. Anatomically safe sites for intramuscular injections: a cross-sectional study on young adults and cadavers with a focus on the thigh. Human Vaccines & Immunotherapeutics, 2019. 16(1), 189-196. https://doi.org/10.1080/21645515.2019.1646576
- Cdc.gov (2021). Retrieved 23 May 2021, from https://www.cdc.gov/vaccines/hcp/conversations/downloads/vacsafe-understand-color-office.pdf
- Ryzhikov, A., Ryzhikov, Е., Bogryantseva, M., Usova, S., Danilenko, E., & Nechaeva, E. et al. A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18–60 years (phase I–II). Russian Journal of Infection and Immunity, 2021. 11(2), 283-296. https://doi.org/10.15789/2220-7619-asb-1699
- Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19 - Full Text View - ClinicalTrials. gov. Clinicaltrials.gov 2021. Retrieved 23 May 2021, from https://clinicaltrials.gov/ct2/show/NCT04780035
- All you need to know about COVID-19 and Vaccines (National Institute for Communicable Diseases). 2021. 3(1), 77. https://doi.org/10.18772/26180197.2021.v3n1a16
- How Gamaleya’s Vaccine Works. Nytimes.com 2021. Retrieved 23 May 2021, from https://www.nytimes.com/interactive/2021/health/gamaleya-covid-19-vaccine.html
- FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine. U.S. Food and Drug Administration. 2021. Retrieved 23 May 2021, from https://www.fda.gov/news-events/press-announcements/fda-takes-additional-action-fight-against-covid-19-issuing-emergency-use-authorization-second-covid
- Information about the Pfizer-BioNTech COVID-19 Vaccine. Centers for Disease Control and Prevention. 2021. Retrieved 23 May 2021, from https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Pfizer-BioNTech.html
- Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, et al. "Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial". The Lancet. Infectious Diseases. October 2020. 21 (1): 39–51. doi:10.1016/s1473-3099(20)30831-8. PMC 7561304. PMID 33069281.
- Xia S, Duan K, Zhang Y, Zhao D, Zhang H, Xie Z, et al.. "Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials". JAMA. September 2020.324 (10): 951–960. doi:10.1001/jama.2020.15543. PMC 7426884. PMID 32789505.
- Vergara, Eva. "Big Chile study finds Chinese vaccine slashes COVID deaths". ABC News. Retrieved 16 April 2021.